| Product Code: ETC7381601 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The sterile injectable contract manufacturing import shipments to Grenada in 2024 show a promising expansion in the market, with top exporting countries including India, Saint Lucia, Barbados, Ireland, and Trinidad and Tobago. The shift from high to moderate concentration in the Herfindahl-Hirschman Index (HHI) indicates a more balanced competitive landscape. The impressive Compound Annual Growth Rate (CAGR) of 4.45% from 2020 to 2024 highlights sustained growth, while the notable growth rate of 29.86% from 2023 to 2024 illustrates a significant uptick in demand. Overall, Grenada`s market for sterile injectable contract manufacturing imports is showing positive momentum and attractiveness to international suppliers.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Sterile Injectable Contract Manufacturing Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Sterile Injectable Contract Manufacturing Market - Industry Life Cycle |
3.4 Grenada Sterile Injectable Contract Manufacturing Market - Porter's Five Forces |
3.5 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.6 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
3.7 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume Share, By End-use Outlook, 2021 & 2031F |
4 Grenada Sterile Injectable Contract Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Grenada Sterile Injectable Contract Manufacturing Market Trends |
6 Grenada Sterile Injectable Contract Manufacturing Market, By Types |
6.1 Grenada Sterile Injectable Contract Manufacturing Market, By Molecule Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Molecule Type, 2021- 2031F |
6.1.3 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Small Molecule, 2021- 2031F |
6.1.4 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Large Molecule, 2021- 2031F |
6.2 Grenada Sterile Injectable Contract Manufacturing Market, By Therapeutic Application |
6.2.1 Overview and Analysis |
6.2.2 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.2.4 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.5 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Central Nervous System Diseases, 2021- 2031F |
6.2.6 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Infectious Disorders, 2021- 2031F |
6.2.7 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Musculoskeletal, 2021- 2031F |
6.3 Grenada Sterile Injectable Contract Manufacturing Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Subcutaneous (SC), 2021- 2031F |
6.3.3 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Intravenous (IV), 2021- 2031F |
6.3.4 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Intramuscular (IM), 2021- 2031F |
6.3.5 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Grenada Sterile Injectable Contract Manufacturing Market, By End-use Outlook |
6.4.1 Overview and Analysis |
6.4.2 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.4.3 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Biopharmaceutical Companies, 2021- 2031F |
6.4.4 Grenada Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 Grenada Sterile Injectable Contract Manufacturing Market Import-Export Trade Statistics |
7.1 Grenada Sterile Injectable Contract Manufacturing Market Export to Major Countries |
7.2 Grenada Sterile Injectable Contract Manufacturing Market Imports from Major Countries |
8 Grenada Sterile Injectable Contract Manufacturing Market Key Performance Indicators |
9 Grenada Sterile Injectable Contract Manufacturing Market - Opportunity Assessment |
9.1 Grenada Sterile Injectable Contract Manufacturing Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.2 Grenada Sterile Injectable Contract Manufacturing Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
9.3 Grenada Sterile Injectable Contract Manufacturing Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Grenada Sterile Injectable Contract Manufacturing Market Opportunity Assessment, By End-use Outlook, 2021 & 2031F |
10 Grenada Sterile Injectable Contract Manufacturing Market - Competitive Landscape |
10.1 Grenada Sterile Injectable Contract Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Grenada Sterile Injectable Contract Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here